New drug ABBV-519 enters first human tests for lupus and arthritis

NCT ID NCT07607964

Recruiting now Disease control Sponsor: AbbVie Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 2 times

Summary

This early-stage study tests a single dose of ABBV-519 in 30 adults with moderate lupus or rheumatoid arthritis. Researchers will check how the drug moves through the body, how it affects immune cells, and whether it is safe. Participants will be followed for about a year to monitor side effects and immune response.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

rheumatoid arthritis systemic lupus erythematosus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RHEUMATOID ARTHRITIS SYSTEMIC LUPUS ERYTHEMATOSUS

Contacts and locations

Locations

Advanced Quality Medical Research /ID# 279147
RECRUITING

Orland Park, Illinois, 60462, United States
Clinical Research Of West Florida - Phase I Unit /ID# 279292
RECRUITING

Clearwater, Florida, 33765, United States
Clinical Research Of West Florida - Tampa - North Howard Avenue /ID# 279130
RECRUITING

Tampa, Florida, 33606, United States
Clinical Research of Osceola /ID# 278374
RECRUITING

Kissimmee, Florida, 34741, United States
Discovery Health Research Center /ID# 279691
RECRUITING

Plantation, Florida, 33317, United States
Epic Medical Research /ID# 279180
RECRUITING

Red Oak, Texas, 75154, United States
Finlay Medical Research - Greenacres /ID# 278380
RECRUITING

Greenacres City, Florida, 33467, United States
Pinnacle Research Group /ID# 278677
RECRUITING

Anniston, Alabama, 36207, United States
Solace Research /ID# 279155
RECRUITING

Tustin, California, 92780, United States
UCLA Health West Medical Campus /ID# 282811
WITHDRAWN

Los Angeles, California, 90095, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.